Abbott files suit against Watson over generic NIASPAN Watson Pharmaceuticals, Inc. today verified that its subsidiary, Watson Laboratories, Inc.S. Food and Drug Administration seeking acceptance to market Niacin Extended-release Tablets, 500 mg and 1000 mg. Abbott Abbott and Laboratories Respiratory LLC filed match against Watson on March 16, 2012, in the United States District Courtroom for the District of Delaware wanting to prevent Watson from commercializing its ANDA products before the expiration of U.S. Patent Nos. 6,080,428 and 6,469,035.S. Product sales of approximately $1.2 billion according to IMS Health data.Clinical trials are had a need to study these opportunities as well. 5 – Mesothelioma cancer clinical trials do not generally involve the usage of a placebo A placebo is an inactive ingredient or pill used in some types of scientific trials to help make sure email address details are unbiased. A placebo may also be called a sugar tablet. Over the years, doctors have noticed that some individuals begin to feel better even if indeed they just think they’re getting treated.